| pubmed-article:1524898 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0024881 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C1516985 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0441766 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0205276 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0039694 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:1524898 | lifeskim:mentions | umls-concept:C2347858 | lld:lifeskim |
| pubmed-article:1524898 | pubmed:issue | 4-5 | lld:pubmed |
| pubmed-article:1524898 | pubmed:dateCreated | 1992-10-19 | lld:pubmed |
| pubmed-article:1524898 | pubmed:abstractText | A (modified) radical mastectomy (RM) was compared with breast-conserving therapy (BCT) in stage I and stage II breast cancer patients. Treatment of the study arm comprised lumpectomy, axillary clearance and radiotherapy to the breast (50 Gy in 5 weeks external irradiation and a boost with iridium implant of 25 Gy). 902 patients were included. There were 734 TNM stage II patients. Patients with microscopically incomplete excision of the tumour were not excluded. After a median follow-up of 6 years, overall survival and local recurrence rates do not differ significantly between the two study arms. Actuarial survival at 8 years was 73% after RM and 71% after BCT; actuarial local recurrence at 8 years was 9% and 15%, respectively. In the mastectomy group tumour size did not affect local relapse, but after BCT the incidence of local recurrences was higher for tumours of 2-5 cm (16%) than for smaller tumours (7%) (at 8 years, P = 0.08). Results of salvage treatment for local recurrence so far were similar in both the BCT and the mastectomy group. | lld:pubmed |
| pubmed-article:1524898 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1524898 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1524898 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1524898 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1524898 | pubmed:issn | 0959-8049 | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:WinterJJ | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:SylvesterRR | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:TonoLL | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:LerutTT | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:van DongenJ... | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:FentimanI SIS | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:OlthuisGG | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:BartelinkHH | lld:pubmed |
| pubmed-article:1524898 | pubmed:author | pubmed-author:MignoletFF | lld:pubmed |
| pubmed-article:1524898 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1524898 | pubmed:volume | 28A | lld:pubmed |
| pubmed-article:1524898 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1524898 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:1524898 | pubmed:pagination | 801-5 | lld:pubmed |
| pubmed-article:1524898 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:meshHeading | pubmed-meshheading:1524898-... | lld:pubmed |
| pubmed-article:1524898 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1524898 | pubmed:articleTitle | Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. | lld:pubmed |
| pubmed-article:1524898 | pubmed:affiliation | Department of Surgery, The Netherlands Cancer Institute, Amsterdam. | lld:pubmed |
| pubmed-article:1524898 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1524898 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1524898 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1524898 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1524898 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1524898 | lld:pubmed |
